BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16160163)

  • 1. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections.
    Meier UC; Owen RE; Taylor E; Worth A; Naoumov N; Willberg C; Tang K; Newton P; Pellegrino P; Williams I; Klenerman P; Borrow P
    J Virol; 2005 Oct; 79(19):12365-74. PubMed ID: 16160163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C.
    Kokordelis P; Krämer B; Boesecke C; Voigt E; Ingiliz P; Glässner A; Wolter F; Srassburg CP; Spengler U; Rockstroh JK; Nattermann J
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):338-46. PubMed ID: 26509931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High number of CD56(bright) NK-cells and persistently low CD4+ T-cells in a hemophiliac HIV/HCV co-infected patient without opportunistic infections.
    Fregni G; Maresca AF; Jalbert V; Caignard A; Scott-Algara D; Cramer EB; Rouveix E; Béné MC; Capron C
    Virol J; 2013 Jan; 10():33. PubMed ID: 23351719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD56
    Judge CJ; Kostadinova L; Sherman KE; Butt AA; Falck-Ytter Y; Funderburg NT; Landay AL; Lederman MM; Sieg SF; Sandberg JK; Anthony DD
    J Leukoc Biol; 2017 Jul; 102(1):171-184. PubMed ID: 28400540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection.
    Titanji K; Sammicheli S; De Milito A; Mantegani P; Fortis C; Berg L; Kärre K; Travi G; Tassandin C; Lopalco L; Rethi B; Tambussi G; Chiodi F
    Immunology; 2008 Feb; 123(2):164-70. PubMed ID: 17627773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.
    Naluyima P; Eller MA; Laeyendecker O; Quinn TC; Serwadda D; Sewankambo NK; Gray RH; Michael NL; Wabwire-Mangen F; Robb ML; Sandberg JK
    AIDS; 2014 Jun; 28(9):1273-8. PubMed ID: 24959961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.
    Miyagi T; Shimizu S; Tatsumi T; Nishio K; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    J Gastroenterol; 2011 Aug; 46(8):1020-30. PubMed ID: 21559771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
    Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG
    Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of natural killer cells during acute infection with hepatitis C virus.
    Amadei B; Urbani S; Cazaly A; Fisicaro P; Zerbini A; Ahmed P; Missale G; Ferrari C; Khakoo SI
    Gastroenterology; 2010 Apr; 138(4):1536-45. PubMed ID: 20080094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
    Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
    J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in NK cell counts and receptor expressions and emergence of CD3(dim)/CD56+ cells in HIV-1 infected patients in China.
    Fu GF; Hao S; Zhao JL; Xu XQ; Guo HX; Hu HY; Yang HT; Li L; Xu JS; Qiu T; Huan XP; Hou YY
    Viral Immunol; 2009 Apr; 22(2):105-16. PubMed ID: 19326997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
    Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
    Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-21 differentially affects human natural killer cell subsets.
    Wendt K; Wilk E; Buyny S; Schmidt RE; Jacobs R
    Immunology; 2007 Dec; 122(4):486-95. PubMed ID: 17635612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantation.
    Yamagiwa S; Sato Y; Ichida T; Setsu T; Tominaga K; Kamimura H; Tsuchiya A; Takamura M; Matsuda Y; Aoyagi Y
    Biomed Res; 2014; 35(3):177-84. PubMed ID: 24942856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
    Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
    J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.
    Golden-Mason L; Cox AL; Randall JA; Cheng L; Rosen HR
    Hepatology; 2010 Nov; 52(5):1581-9. PubMed ID: 20812318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.